| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
33,789 |
31,304 |
$2.56M |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
11,866 |
11,263 |
$1.25M |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
6,409 |
6,335 |
$652K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
6,734 |
6,490 |
$632K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
3,460 |
3,426 |
$350K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
1,219 |
1,204 |
$133K |
| 99215 |
Prolong outpt/office vis |
513 |
493 |
$78K |
| 90686 |
|
4,949 |
4,889 |
$64K |
| 99499 |
|
2,402 |
2,375 |
$64K |
| 99429 |
|
2,401 |
2,367 |
$63K |
| 92552 |
|
2,154 |
2,125 |
$46K |
| D0120 |
Periodic oral evaluation - established patient |
1,441 |
1,425 |
$38K |
| 90670 |
|
2,130 |
2,091 |
$33K |
| D9999 |
Unspecified adjunctive procedure, by report |
1,326 |
1,311 |
$32K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
1,545 |
1,499 |
$31K |
| 99188 |
|
2,228 |
1,994 |
$27K |
| 90680 |
|
1,167 |
1,145 |
$19K |
| 96160 |
|
5,670 |
5,471 |
$18K |
| 96127 |
|
3,456 |
2,829 |
$17K |
| 90472 |
Immunization administration, each additional vaccine (list separately) |
611 |
601 |
$16K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
1,558 |
1,208 |
$15K |
| 90688 |
|
1,096 |
1,083 |
$15K |
| 90698 |
|
1,216 |
1,201 |
$14K |
| 90697 |
|
714 |
699 |
$14K |
| 99173 |
|
4,344 |
4,299 |
$8K |
| 90671 |
|
371 |
370 |
$8K |
| 90677 |
|
426 |
414 |
$6K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
124 |
123 |
$6K |
| 0071A |
|
134 |
132 |
$5K |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
250 |
241 |
$5K |
| 90480 |
|
156 |
153 |
$5K |
| 90656 |
|
634 |
621 |
$4K |
| 90633 |
|
267 |
260 |
$4K |
| 90651 |
|
274 |
274 |
$4K |
| 0072A |
|
90 |
90 |
$4K |
| 96161 |
|
1,230 |
1,168 |
$3K |
| 90685 |
|
159 |
158 |
$2K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
141 |
83 |
$2K |
| D1206 |
Topical application of fluoride varnish |
98 |
96 |
$2K |
| 94760 |
|
1,924 |
1,767 |
$1K |
| 96380 |
|
71 |
68 |
$1K |
| 90744 |
|
127 |
125 |
$1K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
59 |
57 |
$981.47 |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
4,629 |
4,513 |
$972.22 |
| 90619 |
|
41 |
41 |
$878.21 |
| 86317 |
|
65 |
64 |
$840.53 |
| 90672 |
|
28 |
26 |
$540.00 |
| 0004A |
|
13 |
13 |
$520.00 |
| 0112A |
|
12 |
12 |
$516.00 |
| 99177 |
|
159 |
159 |
$480.76 |
| 90461 |
|
2,444 |
2,377 |
$432.48 |
| 90473 |
|
13 |
13 |
$223.18 |
| 99051 |
|
297 |
292 |
$154.00 |
| 91321 |
|
56 |
56 |
$146.12 |
| 90660 |
|
13 |
13 |
$37.18 |
| 99001 |
|
51 |
50 |
$12.00 |
| 99072 |
|
1,122 |
1,068 |
$0.00 |
| 91311 |
|
50 |
48 |
$0.00 |
| 91300 |
|
18 |
18 |
$0.00 |
| G8510 |
Screening for depression is documented as negative, a follow-up plan is not required |
665 |
660 |
$0.00 |
| 99000 |
|
577 |
563 |
$0.00 |
| 99070 |
|
79 |
78 |
$0.00 |